Peter Genco | |
5203 Main St South Fallsburg NY 12779-5422 | |
(845) 434-1202 | |
Not Available |
Full Name | Peter Genco |
---|---|
Speciality | Clinic/center - Dental |
Location | 5203 Main St, South Fallsburg, New York |
Authorized Official Name and Position | Peter A Genco (DMD) |
Authorized Official Contact | 8454341202 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Peter Genco 5203 Main St South Fallsburg NY 12779-5422 Ph: (845) 434-1202 | Peter Genco 5203 Main St South Fallsburg NY 12779-5422 Ph: (845) 434-1202 |
NPI Number | 1942703251 |
---|---|
Provider Enumeration Date | 03/13/2018 |
Last Update Date | 03/13/2018 |
Identifier | Type | State | Issuer |
---|---|---|---|
1942703251 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QD0000X | Clinic/center - Dental | 049937-1 (New York) | Primary |
News Archive
Infectious disease specialists at UT Southwestern Medical Center have found a new method for identifying suspect viruses and bacteria that cause some of the most common acute infections in children.
A new poll finds that regardless of the Supreme Court's decision, less than a majority of Americans will be happy with the outcome. Republican voters, however, are more open to the idea of the court nullifying part of the law. Meanwhile, even if the law is upheld, an estimated 26 million people will still go without insurance, including illegal immigrants and those eligible for Medicaid but who don't enroll.
A new Cochrane Review, published in the Cochrane Library today and presented at the ERS International Congress, has found evidence from randomised trials, that taking an oral vitamin D supplement in addition to standard asthma medication is likely to reduce severe asthma attacks.
Early results from an innovative new clinical trial led by researchers from Queen's University Belfast have shown that men with prostate cancer could benefit from radical radiotherapy that delivers treatment in just five visits instead of the usual 37.
Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients with type 2 diabetes inadequately controlled with metformin alone, as compared to placebo plus metformin.
› Verified 7 days ago
Family Dentistry Of Sullivan County, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5085 South Fallsburg Main St., South Fallsburg, NY 12779 Phone: 845-434-8444 Fax: 845-434-8440 |